Add BrightSurf on Google Email

Aging reimagined: UT Health San Antonio study shifts focus from inevitable decline to optimizing resilience

Researchers discovered that individuals with robust immune resilience at midlife can gain a 15.5-year survival advantage due to their ability to counter disease drivers and maintain healthy aging. The study highlights the importance of salutogenesis, or promoting health and well-being from birth to approximately age 70.

SourceUniversity of Texas Health Science Center at San Antonio·JournalAging Cell·TypeData/statistical analysis·DateApr 23, 2025

COVID-19 vaccination induces long-lasting antibody B-cell responses

A study of 113 healthcare workers found that COVID-19 mRNA vaccination induces long-lasting antibody and memory B-cell responses, even in those previously exposed to the virus. The research team also discovered an association between higher levels of specific antibodies and increased risk of breakthrough infections.

SourceBarcelona Institute for Global Health (ISGlobal)·JournalCell Reports·TypeExperimental study·DateApr 8, 2025

New findings on T cell exhaustion: The body prepares early for mild to severe disease

A recent study by researchers at TUM has discovered that the body produces special T cells predisposed to exhaustion even in early infection phases of moderate diseases. This finding expands our understanding of immune response mechanisms and could help control the immune system in cancer patients or weaken excessive defenses.

SourceTechnical University of Munich (TUM)·JournalNature·TypeExperimental study·DateApr 7, 2025

Researchers find intestinal immune cell prevents food allergies

A recent study published in Cell revealed that a specific intestinal immune cell prevents food allergies by breaking the threshold between friend and foe in the gut. Researchers at WashU Medicine identified this cell as RORγt+ dendritic cells, which maintain tolerance to harmless food allergens, preventing allergic reactions.

SourceWashU Medicine·JournalCell·TypeExperimental study·DateApr 3, 2025

Getting cancer to unmask itself

Researchers from Prof. Yardena Samuels's lab developed a new approach to cancer treatment by manipulating cancer cells to produce dozens of suspicious proteins, leading to a powerful immune response that destroys human cancer cells and slows tumor growth in mouse models.

SourceWeizmann Institute of Science·JournalCancer Cell·DateMar 31, 2025

CNIO research reveals how melanoma and other tumours succeed in hiding and resisting immunotherapy

A recent study by the CNIO Melanoma Group has discovered a mechanism by which melanomas evade immune system surveillance. The research found that melanoma cells secrete Midkine, a protein that reduces dendritic cell numbers and reprograms their function to promote tumour development.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalNature Cancer·TypeExperimental study·DateMar 28, 2025

Protein in the nose provides information about COPD

Researchers at Karolinska Institutet have developed a new method to diagnose COPD by analyzing protein levels in nasal lavage. The study found that elevated IL-26 levels can indicate an early phase of the disease, and may lead to new treatment strategies targeting this cytokine.

SourceKarolinska Institutet·JournalJournal of Allergy and Clinical Immunology·TypeExperimental study·DateMar 28, 2025

Understanding the immune response to a persistent pathogen

A team of researchers from the University of Pennsylvania School of Veterinary Medicine has made a groundbreaking discovery about the immune system's response to the latent stage of Toxoplasma gondii. The study found that certain T cells can target neurons containing cysts, promoting parasite control. However, this process also poses a...

SourceUniversity of Pennsylvania·JournalNature Microbiology·TypeExperimental study·DateMar 28, 2025

How Zika virus knocks out our immune defenses

Researchers from La Jolla Institute for Immunology and UC San Diego discover Zika virus blocks dendritic cells' ability to alert T cells, while dengue virus stimulates pro-inflammatory cytokines, leading to a stronger but uncontrolled immune response. Understanding these differences is key to developing life-saving vaccines.

SourceLa Jolla Institute for Immunology·JournalNature Communications·TypeExperimental study·DateMar 25, 2025

NUS Medicine study: Breaking antibiotic-resistant bacteria’s protective shields opens door for immune system response, offers insights for managing pneumococcal diseases

Researchers have made progress in understanding how Streptococcus pneumoniae constructs its capsule, a critical target for vaccine development. The study identified three categories of transporters that facilitate sugar building block transport, with relaxed specificity transporters posing potential risks to bacterial growth.

Researchers find missing link in autoimmune disorder

Scientists have identified a key component in launching immune activity and overactivity, providing a potential target for therapies that could prevent debilitating illnesses. The researchers discovered a protein in cells that spurs the release of infection-fighting molecules, which is essential for controlling the disease.

SourceWashU Medicine·JournalCell·TypeExperimental study·DateMar 18, 2025

New immune-probing technique could boost treatment discovery

Researchers at Osaka University developed a new technique called single-cell suppressive profiling of regulatory T cells (scSPOT) that can pinpoint the effects of Tregs on all other immune cells. The study found that Tregs most strongly affect CD8-EM T cells, which play a key role in fighting cancer and infections.

SourceOsaka University·JournalNature Communications·TypeExperimental study·DateFeb 12, 2025

From Spanish flu to today: how immune cells keep up with a changing virus

Researchers discovered immune cells that can recognise influenza (flu) viruses even as they mutate, providing a potential solution to the annual updates of flu vaccines. The study found that certain T cells, which play a critical role in fighting infections, can detect multiple flu strains, even those that have evolved over a century.

SourceUniversity of Melbourne·JournalScience Immunology·TypeExperimental study·DateFeb 10, 2025

Skin disease patients show response to targeted treatment

Researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition. The treatment, baricitinib, selectively blocks specific inflammatory pathways, reducing inflammation and suppressing the overactive immune response that contributes to the disease.

SourceMayo Clinic·JournalJournal of Clinical Investigation·DateFeb 3, 2025